An abnormal metabolism-related gene, ALG3, is a potential diagnostic and prognostic biomarker for lung adenocarcinoma
To explore the abnormal metabolism-related genes that affect the prognosis of patients with lung adenocarcinoma (LUAD), and analyze the relationship with immune infiltration and competing endogenous RNA (ceRNA) network. Transcriptome data of LUAD were downloaded from the Cancer Genome Atlas database...
Gespeichert in:
| Veröffentlicht in: | Medicine (Baltimore) 2024-09, Vol.103 (37), p.e38746 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 37 |
| container_start_page | e38746 |
| container_title | Medicine (Baltimore) |
| container_volume | 103 |
| creator | Reyimu, Abdusemer Cheng, Xiang Liu, Wen Kaisaier, Aihemaitijiang Wang, Xinying Sha, Yinzhong Guo, Ruijie Paerhati, Pawuziye Maimaiti, Maimaituxun He, Chuanjiang Li, Li Zou, Xiaoguang Xu, Aimin |
| description | To explore the abnormal metabolism-related genes that affect the prognosis of patients with lung adenocarcinoma (LUAD), and analyze the relationship with immune infiltration and competing endogenous RNA (ceRNA) network.
Transcriptome data of LUAD were downloaded from the Cancer Genome Atlas database. Abnormal metabolism-related differentially expressed genes in LUAD were screened by the R language. Cox analysis was used to construct LUAD prognostic risk model. Kaplan-Meier test, ROC curve and nomograms were used to evaluate the predictive ability of metabolic related gene prognostic model. CIBERSORT algorithm was used to analyze the relationship between risk score and immune infiltration. The starBase database constructed a regulatory network consistent with the ceRNA hypothesis. IHC experiments were performed to verify the differential expression of ALG3 in LUAD and paracancerous samples.
In this study, 42 abnormal metabolism-related differential genes were screened. After survival analysis, the final 5 metabolism-related genes were used as the construction of prognosis model, including ALG3, COL7A1, KL, MST1, and SLC52A1. In the model, the survival rate of LUAD patients in the high-risk subgroup was lower than that in the low-risk group. In addition, the risk score of the constructed LUAD prognostic model can be used as an independent prognostic factor for patients. According to the analysis of CIBERSORT algorithm, the risk score is related to the infiltration of multiple immune cells. The potential ceRNA network of model genes in LUAD was constructed through the starBase database. IHC experiments revealed that ALG3 expression was upregulated in LUAD.
The prognostic model of LUAD reveals the relationship between metabolism and prognosis of LUAD, and provides a novel perspective for diagnosis and research of LUAD. |
| doi_str_mv | 10.1097/MD.0000000000038746 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11404934</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3106457804</sourcerecordid><originalsourceid>FETCH-LOGICAL-c286t-e9f12bde3c5abac05ba61f928b9b1ca85223d36a0a5f04b1027c2f59492554f3</originalsourceid><addsrcrecordid>eNpdUclKxTAUDaLoc_gCQbJ0YTVj26zk4QxP3LgPN2n6jLbJM2kF_96Ks3dzuZzhHjgI7VNyTImqTm7Pj8nP8LoS5RqaUcnLQqpSrKMZIUwWlarEFtrO-ZEQyismNtEWV6yuGKczNM4DBhNi6qHDvRvAxM7nvkiug8E1eOmCO8LzxRU_wj5jwKs4uDD4id14WIaYB28xhAavUvw6jY89pCeXcBsT7sawxNC4EC0k68OE7aKNFrrs9j73Drq_vLg_uy4Wd1c3Z_NFYVldDoVTLWWmcdxKMGCJNFDSdspulKEWaskYb3gJBGRLhKGEVZa1UgnFpBQt30GnH7ar0fSusVPwBJ1eJT_Fe9URvP6LBP-gl_FFUyqIUFxMDoefDik-jy4PuvfZuq6D4OKYNaekFLKqyTuVf1Btijkn137_oUS_F6Zvz_X_wibVwe-I35qvhvgbT3CTDg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3106457804</pqid></control><display><type>article</type><title>An abnormal metabolism-related gene, ALG3, is a potential diagnostic and prognostic biomarker for lung adenocarcinoma</title><source>Wolters Kluwer Open Health</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>IngentaConnect Free/Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Reyimu, Abdusemer ; Cheng, Xiang ; Liu, Wen ; Kaisaier, Aihemaitijiang ; Wang, Xinying ; Sha, Yinzhong ; Guo, Ruijie ; Paerhati, Pawuziye ; Maimaiti, Maimaituxun ; He, Chuanjiang ; Li, Li ; Zou, Xiaoguang ; Xu, Aimin</creator><creatorcontrib>Reyimu, Abdusemer ; Cheng, Xiang ; Liu, Wen ; Kaisaier, Aihemaitijiang ; Wang, Xinying ; Sha, Yinzhong ; Guo, Ruijie ; Paerhati, Pawuziye ; Maimaiti, Maimaituxun ; He, Chuanjiang ; Li, Li ; Zou, Xiaoguang ; Xu, Aimin</creatorcontrib><description>To explore the abnormal metabolism-related genes that affect the prognosis of patients with lung adenocarcinoma (LUAD), and analyze the relationship with immune infiltration and competing endogenous RNA (ceRNA) network.
Transcriptome data of LUAD were downloaded from the Cancer Genome Atlas database. Abnormal metabolism-related differentially expressed genes in LUAD were screened by the R language. Cox analysis was used to construct LUAD prognostic risk model. Kaplan-Meier test, ROC curve and nomograms were used to evaluate the predictive ability of metabolic related gene prognostic model. CIBERSORT algorithm was used to analyze the relationship between risk score and immune infiltration. The starBase database constructed a regulatory network consistent with the ceRNA hypothesis. IHC experiments were performed to verify the differential expression of ALG3 in LUAD and paracancerous samples.
In this study, 42 abnormal metabolism-related differential genes were screened. After survival analysis, the final 5 metabolism-related genes were used as the construction of prognosis model, including ALG3, COL7A1, KL, MST1, and SLC52A1. In the model, the survival rate of LUAD patients in the high-risk subgroup was lower than that in the low-risk group. In addition, the risk score of the constructed LUAD prognostic model can be used as an independent prognostic factor for patients. According to the analysis of CIBERSORT algorithm, the risk score is related to the infiltration of multiple immune cells. The potential ceRNA network of model genes in LUAD was constructed through the starBase database. IHC experiments revealed that ALG3 expression was upregulated in LUAD.
The prognostic model of LUAD reveals the relationship between metabolism and prognosis of LUAD, and provides a novel perspective for diagnosis and research of LUAD.</description><identifier>ISSN: 0025-7974</identifier><identifier>ISSN: 1536-5964</identifier><identifier>EISSN: 1536-5964</identifier><identifier>DOI: 10.1097/MD.0000000000038746</identifier><identifier>PMID: 39287231</identifier><language>eng</language><publisher>United States: Lippincott Williams & Wilkins</publisher><subject>Adenocarcinoma of Lung - genetics ; Adenocarcinoma of Lung - metabolism ; Adenocarcinoma of Lung - mortality ; Biomarkers, Tumor - genetics ; Biomarkers, Tumor - metabolism ; Clinical Trial/Experimental Study ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Kaplan-Meier Estimate ; Lung Neoplasms - diagnosis ; Lung Neoplasms - genetics ; Lung Neoplasms - metabolism ; Lung Neoplasms - mortality ; Male ; Middle Aged ; Nomograms ; Prognosis ; ROC Curve ; Transcriptome</subject><ispartof>Medicine (Baltimore), 2024-09, Vol.103 (37), p.e38746</ispartof><rights>Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.</rights><rights>Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc. 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c286t-e9f12bde3c5abac05ba61f928b9b1ca85223d36a0a5f04b1027c2f59492554f3</cites><orcidid>0000-0002-9323-2390</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11404934/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11404934/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39287231$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Reyimu, Abdusemer</creatorcontrib><creatorcontrib>Cheng, Xiang</creatorcontrib><creatorcontrib>Liu, Wen</creatorcontrib><creatorcontrib>Kaisaier, Aihemaitijiang</creatorcontrib><creatorcontrib>Wang, Xinying</creatorcontrib><creatorcontrib>Sha, Yinzhong</creatorcontrib><creatorcontrib>Guo, Ruijie</creatorcontrib><creatorcontrib>Paerhati, Pawuziye</creatorcontrib><creatorcontrib>Maimaiti, Maimaituxun</creatorcontrib><creatorcontrib>He, Chuanjiang</creatorcontrib><creatorcontrib>Li, Li</creatorcontrib><creatorcontrib>Zou, Xiaoguang</creatorcontrib><creatorcontrib>Xu, Aimin</creatorcontrib><title>An abnormal metabolism-related gene, ALG3, is a potential diagnostic and prognostic biomarker for lung adenocarcinoma</title><title>Medicine (Baltimore)</title><addtitle>Medicine (Baltimore)</addtitle><description>To explore the abnormal metabolism-related genes that affect the prognosis of patients with lung adenocarcinoma (LUAD), and analyze the relationship with immune infiltration and competing endogenous RNA (ceRNA) network.
Transcriptome data of LUAD were downloaded from the Cancer Genome Atlas database. Abnormal metabolism-related differentially expressed genes in LUAD were screened by the R language. Cox analysis was used to construct LUAD prognostic risk model. Kaplan-Meier test, ROC curve and nomograms were used to evaluate the predictive ability of metabolic related gene prognostic model. CIBERSORT algorithm was used to analyze the relationship between risk score and immune infiltration. The starBase database constructed a regulatory network consistent with the ceRNA hypothesis. IHC experiments were performed to verify the differential expression of ALG3 in LUAD and paracancerous samples.
In this study, 42 abnormal metabolism-related differential genes were screened. After survival analysis, the final 5 metabolism-related genes were used as the construction of prognosis model, including ALG3, COL7A1, KL, MST1, and SLC52A1. In the model, the survival rate of LUAD patients in the high-risk subgroup was lower than that in the low-risk group. In addition, the risk score of the constructed LUAD prognostic model can be used as an independent prognostic factor for patients. According to the analysis of CIBERSORT algorithm, the risk score is related to the infiltration of multiple immune cells. The potential ceRNA network of model genes in LUAD was constructed through the starBase database. IHC experiments revealed that ALG3 expression was upregulated in LUAD.
The prognostic model of LUAD reveals the relationship between metabolism and prognosis of LUAD, and provides a novel perspective for diagnosis and research of LUAD.</description><subject>Adenocarcinoma of Lung - genetics</subject><subject>Adenocarcinoma of Lung - metabolism</subject><subject>Adenocarcinoma of Lung - mortality</subject><subject>Biomarkers, Tumor - genetics</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Clinical Trial/Experimental Study</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Kaplan-Meier Estimate</subject><subject>Lung Neoplasms - diagnosis</subject><subject>Lung Neoplasms - genetics</subject><subject>Lung Neoplasms - metabolism</subject><subject>Lung Neoplasms - mortality</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nomograms</subject><subject>Prognosis</subject><subject>ROC Curve</subject><subject>Transcriptome</subject><issn>0025-7974</issn><issn>1536-5964</issn><issn>1536-5964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdUclKxTAUDaLoc_gCQbJ0YTVj26zk4QxP3LgPN2n6jLbJM2kF_96Ks3dzuZzhHjgI7VNyTImqTm7Pj8nP8LoS5RqaUcnLQqpSrKMZIUwWlarEFtrO-ZEQyismNtEWV6yuGKczNM4DBhNi6qHDvRvAxM7nvkiug8E1eOmCO8LzxRU_wj5jwKs4uDD4id14WIaYB28xhAavUvw6jY89pCeXcBsT7sawxNC4EC0k68OE7aKNFrrs9j73Drq_vLg_uy4Wd1c3Z_NFYVldDoVTLWWmcdxKMGCJNFDSdspulKEWaskYb3gJBGRLhKGEVZa1UgnFpBQt30GnH7ar0fSusVPwBJ1eJT_Fe9URvP6LBP-gl_FFUyqIUFxMDoefDik-jy4PuvfZuq6D4OKYNaekFLKqyTuVf1Btijkn137_oUS_F6Zvz_X_wibVwe-I35qvhvgbT3CTDg</recordid><startdate>20240913</startdate><enddate>20240913</enddate><creator>Reyimu, Abdusemer</creator><creator>Cheng, Xiang</creator><creator>Liu, Wen</creator><creator>Kaisaier, Aihemaitijiang</creator><creator>Wang, Xinying</creator><creator>Sha, Yinzhong</creator><creator>Guo, Ruijie</creator><creator>Paerhati, Pawuziye</creator><creator>Maimaiti, Maimaituxun</creator><creator>He, Chuanjiang</creator><creator>Li, Li</creator><creator>Zou, Xiaoguang</creator><creator>Xu, Aimin</creator><general>Lippincott Williams & Wilkins</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-9323-2390</orcidid></search><sort><creationdate>20240913</creationdate><title>An abnormal metabolism-related gene, ALG3, is a potential diagnostic and prognostic biomarker for lung adenocarcinoma</title><author>Reyimu, Abdusemer ; Cheng, Xiang ; Liu, Wen ; Kaisaier, Aihemaitijiang ; Wang, Xinying ; Sha, Yinzhong ; Guo, Ruijie ; Paerhati, Pawuziye ; Maimaiti, Maimaituxun ; He, Chuanjiang ; Li, Li ; Zou, Xiaoguang ; Xu, Aimin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c286t-e9f12bde3c5abac05ba61f928b9b1ca85223d36a0a5f04b1027c2f59492554f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adenocarcinoma of Lung - genetics</topic><topic>Adenocarcinoma of Lung - metabolism</topic><topic>Adenocarcinoma of Lung - mortality</topic><topic>Biomarkers, Tumor - genetics</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Clinical Trial/Experimental Study</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Kaplan-Meier Estimate</topic><topic>Lung Neoplasms - diagnosis</topic><topic>Lung Neoplasms - genetics</topic><topic>Lung Neoplasms - metabolism</topic><topic>Lung Neoplasms - mortality</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nomograms</topic><topic>Prognosis</topic><topic>ROC Curve</topic><topic>Transcriptome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Reyimu, Abdusemer</creatorcontrib><creatorcontrib>Cheng, Xiang</creatorcontrib><creatorcontrib>Liu, Wen</creatorcontrib><creatorcontrib>Kaisaier, Aihemaitijiang</creatorcontrib><creatorcontrib>Wang, Xinying</creatorcontrib><creatorcontrib>Sha, Yinzhong</creatorcontrib><creatorcontrib>Guo, Ruijie</creatorcontrib><creatorcontrib>Paerhati, Pawuziye</creatorcontrib><creatorcontrib>Maimaiti, Maimaituxun</creatorcontrib><creatorcontrib>He, Chuanjiang</creatorcontrib><creatorcontrib>Li, Li</creatorcontrib><creatorcontrib>Zou, Xiaoguang</creatorcontrib><creatorcontrib>Xu, Aimin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Medicine (Baltimore)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Reyimu, Abdusemer</au><au>Cheng, Xiang</au><au>Liu, Wen</au><au>Kaisaier, Aihemaitijiang</au><au>Wang, Xinying</au><au>Sha, Yinzhong</au><au>Guo, Ruijie</au><au>Paerhati, Pawuziye</au><au>Maimaiti, Maimaituxun</au><au>He, Chuanjiang</au><au>Li, Li</au><au>Zou, Xiaoguang</au><au>Xu, Aimin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An abnormal metabolism-related gene, ALG3, is a potential diagnostic and prognostic biomarker for lung adenocarcinoma</atitle><jtitle>Medicine (Baltimore)</jtitle><addtitle>Medicine (Baltimore)</addtitle><date>2024-09-13</date><risdate>2024</risdate><volume>103</volume><issue>37</issue><spage>e38746</spage><pages>e38746-</pages><issn>0025-7974</issn><issn>1536-5964</issn><eissn>1536-5964</eissn><abstract>To explore the abnormal metabolism-related genes that affect the prognosis of patients with lung adenocarcinoma (LUAD), and analyze the relationship with immune infiltration and competing endogenous RNA (ceRNA) network.
Transcriptome data of LUAD were downloaded from the Cancer Genome Atlas database. Abnormal metabolism-related differentially expressed genes in LUAD were screened by the R language. Cox analysis was used to construct LUAD prognostic risk model. Kaplan-Meier test, ROC curve and nomograms were used to evaluate the predictive ability of metabolic related gene prognostic model. CIBERSORT algorithm was used to analyze the relationship between risk score and immune infiltration. The starBase database constructed a regulatory network consistent with the ceRNA hypothesis. IHC experiments were performed to verify the differential expression of ALG3 in LUAD and paracancerous samples.
In this study, 42 abnormal metabolism-related differential genes were screened. After survival analysis, the final 5 metabolism-related genes were used as the construction of prognosis model, including ALG3, COL7A1, KL, MST1, and SLC52A1. In the model, the survival rate of LUAD patients in the high-risk subgroup was lower than that in the low-risk group. In addition, the risk score of the constructed LUAD prognostic model can be used as an independent prognostic factor for patients. According to the analysis of CIBERSORT algorithm, the risk score is related to the infiltration of multiple immune cells. The potential ceRNA network of model genes in LUAD was constructed through the starBase database. IHC experiments revealed that ALG3 expression was upregulated in LUAD.
The prognostic model of LUAD reveals the relationship between metabolism and prognosis of LUAD, and provides a novel perspective for diagnosis and research of LUAD.</abstract><cop>United States</cop><pub>Lippincott Williams & Wilkins</pub><pmid>39287231</pmid><doi>10.1097/MD.0000000000038746</doi><orcidid>https://orcid.org/0000-0002-9323-2390</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0025-7974 |
| ispartof | Medicine (Baltimore), 2024-09, Vol.103 (37), p.e38746 |
| issn | 0025-7974 1536-5964 1536-5964 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11404934 |
| source | Wolters Kluwer Open Health; MEDLINE; DOAJ Directory of Open Access Journals; IngentaConnect Free/Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Alma/SFX Local Collection |
| subjects | Adenocarcinoma of Lung - genetics Adenocarcinoma of Lung - metabolism Adenocarcinoma of Lung - mortality Biomarkers, Tumor - genetics Biomarkers, Tumor - metabolism Clinical Trial/Experimental Study Female Gene Expression Regulation, Neoplastic Humans Kaplan-Meier Estimate Lung Neoplasms - diagnosis Lung Neoplasms - genetics Lung Neoplasms - metabolism Lung Neoplasms - mortality Male Middle Aged Nomograms Prognosis ROC Curve Transcriptome |
| title | An abnormal metabolism-related gene, ALG3, is a potential diagnostic and prognostic biomarker for lung adenocarcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T01%3A16%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20abnormal%20metabolism-related%20gene,%20ALG3,%20is%20a%20potential%20diagnostic%20and%20prognostic%20biomarker%20for%20lung%20adenocarcinoma&rft.jtitle=Medicine%20(Baltimore)&rft.au=Reyimu,%20Abdusemer&rft.date=2024-09-13&rft.volume=103&rft.issue=37&rft.spage=e38746&rft.pages=e38746-&rft.issn=0025-7974&rft.eissn=1536-5964&rft_id=info:doi/10.1097/MD.0000000000038746&rft_dat=%3Cproquest_pubme%3E3106457804%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3106457804&rft_id=info:pmid/39287231&rfr_iscdi=true |